Issue Highlights - May 2018
Update: 2018-11-12
Description
New systematic review looks at patient-reported outcome measures for IBD. New research highlights the importance of standardizing measures for clinical trials of ulcerative colitis. Identification of new biomarkers to guide vedolizumab use is necessary for treatment of IBD. Two articles by the same research group review topical issues in the management of IBD.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
